Research Topics
Genomes and Genes | Michel FeletouSummaryAffiliation: Institut de Recherches Servier Country: France Publications
| Collaborators
|
Detail Information
Publications
NPY receptors as drug targets for the central regulation of body weightMichel Feletou
Department of Angiology, Suresnes and Croissy Sur Seine, France
CNS Neurol Disord Drug Targets 5:263-74. 2006..Whether this will be the long awaited therapy based on manipulation of NPY receptors will await further studies of long term efficacy and more importantly a favorable side effect profile...
Vasoconstrictor prostanoidsMichel Feletou
Institut Recherches Servier, Suresnes, France
Pflugers Arch 459:941-50. 2010..TP receptor antagonists curtail endothelial dysfunction in diseases such as hypertension and diabetes, are potent antithrombotic agents, and prevent vascular inflammation...
Endothelium-mediated control of vascular tone: COX-1 and COX-2 productsMichel Feletou
Institut Recherches Servier, Suresnes, France
Br J Pharmacol 164:894-912. 2011....
Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptorsMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Br J Pharmacol 156:563-74. 2009..Nevertheless, because EDCFs converge to activate TP receptors, selective antagonists of this receptor, by preventing endothelium-dependent contractions, curtail the endothelial dysfunction in diseases such as hypertension and diabetes...
[Communication between endothelial and smooth muscle cells]Michel Feletou
Institut de Recherches Servier, 92150 Suresnes, France
Med Sci (Paris) 19:1242-50. 2003..The discovery of specific inhibitors of the endothelial cell hyperpolarization allows the assessment of the contribution of EDHF-mediated responses in the control of vascular tone...
EDHF: new therapeutic targets?Michel Feletou
Département Diabète et Maladies Métaboliques, Institut de Recherches Servier, 11 rue des Moulineaux, 92150 Suresnes, France
Pharmacol Res 49:565-80. 2004..Activating endothelial IK(Ca) and/or SK(Ca) or increasing their expression as well as improving myo-endothelial communication, for instance by increasing the expression of connexin(s), could become interesting therapeutic targets...
Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?Michel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Br J Pharmacol 156:545-62. 2009..Conversely, blockers of IK(Ca) may prevent restenosis and that of BK(Ca) channels sepsis-dependent hypotension...
EDHF: an updateMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Clin Sci (Lond) 117:139-55. 2009..A better characterization of EDHF-mediated responses should allow the determination of whether or not new drugable targets can be identified for the treatment of cardiovascular diseases...
Aging and prostacyclin responses in aorta and platelets from WKY and SHR ratsElodie Gomez
Départment d Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux 92150 Suresnes, France
Am J Physiol Heart Circ Physiol 295:H2198-211. 2008..In aorta from WKY those responses are reduced by aging and, in SHR, are already compromised at 3 mo. This dysfunction of the IP receptor is only partially explained by a general dysfunction of the adenylate cyclase pathway...
KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOSSerge Simonet
Institut de Recherches Servier, Suresnes, France
Br J Pharmacol 167:854-67. 2012..The purpose of the study was to investigate renal endothelium-dependent vasodilatation in a model of severe hypertension associated with kidney injury...
Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclaseSéverine Roger
Institut Recherches Servier, Suresnes, France
Vascul Pharmacol 53:281-7. 2010..When the sGC is oxidized, BAY 58-2667 becomes a relevant anti-aggregating agent, which synergizes with the cAMP-dependent pathway...
Mechanisms underlying ATP-induced endothelium-dependent contractions in the SHR aortaPascale Gluais
Institut de Recherches Servier, 92150 Suresnes, France
Eur J Pharmacol 556:107-14. 2007..Thus, in the aorta of SHR, endothelium-dependent contractions elicited by ATP involve the release of thromboxane A(2) and prostacyclin with a possible contribution of PGH(2)...
Endothelium-dependent hyperpolarization to acetylcholine in carotid artery of guinea pig: role of lipoxygenaseJean François Quignard
Département Diabète et Maladies Métaboliques, Institut de Recherches Servier, Suresnes, France
J Cardiovasc Pharmacol 40:467-77. 2002....
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)Michel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Am J Physiol Heart Circ Physiol 291:H985-1002. 2006..Therapeutic interventions do not necessarily restore a proper endothelial function and, when they do, may improve only part of these variables...
Nitric oxide the gatekeeper of endothelial vasomotor controlMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Front Biosci 13:4198-217. 2008..Among the diffusible endothelial factors nitric oxide (NO) plays a key role, particularly in large blood vessels. This chapter briefly reviews the interactions between NO and the other vasomotor signals released by the endothelial cells...
Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclinPascale Gluais
Institut de Recherches Servier, 92150 Suresnes, France
Br J Pharmacol 146:834-45. 2005..Thus, in the aorta of SHR and aging WKY, the endothelium-dependent contractions elicited by acetylcholine most likely involve the release of PGI2 with a concomitant contribution of PGH2...
The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxideSéverine Roger
Département Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux, Suresnes, France
Br J Pharmacol 161:1044-58. 2010..The purpose of the present study was to determine whether a stimulator of soluble guanylyl cyclase, BAY 41-2272, inhibits platelet aggregation and to clarify its interaction with nitric oxide (NO)...
Endothelium-dependent hyperpolarizations: past beliefs and present factsMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Ann Med 39:495-516. 2007..These various mechanisms are not necessarily mutually exclusive and, depending on the vascular bed and the experimental conditions, can occur simultaneously or sequentially, or also may act synergistically...
Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targetsMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Curr Hypertens Rep 12:267-75. 2010..This brief review highlights these different endothelial pathways as potential drug targets for novel treatments in hypertension and the associated endothelial dysfunction and end-organ damage...
Role of thromboxane TP and angiotensin AT1 receptors in lipopolysaccharide-induced arterial dysfunction in the rabbit: an in vivo studyChristine Vayssettes-Courchay
Division of Angiology, Servier Research Institute, 11 rue des Moulineaux, 92150 Suresnes, France
Eur J Pharmacol 634:113-20. 2010....
Mechanisms of the vasorelaxing effects of CORM-3, a water-soluble carbon monoxide-releasing molecule: interactions with eNOSAli Alshehri
Institut Recherches Servier, Suresnes, France
Naunyn Schmiedebergs Arch Pharmacol 386:185-96. 2013....
Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytesChristelle Merial-Kieny
Département Diabète et Maladies Métaboliques, Institut de Recherche Servier, Suresnes 92150, France
Br J Pharmacol 139:935-44. 2003..6. Thus, these results confirm that adipocytes are a target for circulating ET-1 and demonstrate that the activation of the ETA receptor subtype can prevent TNFalpha-induced iNOS expression...
Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHFRostislav Bychkov
Département Diabète et Maladies Métaboliques, Institut de Recherches Servier, 11 rue des Molineaux, 92150 Suresnes, France
Br J Pharmacol 137:1346-54. 2002..This channel is opened by activation of the EDHF pathway and likely mediates the charybdotoxin-sensitive component of the EDHF response...
K+ channels in cultured bovine retinal pericytes: effects of beta-adrenergic stimulationJean François Quignard
Département Diabète et Maladies Métaboliques, Institut de Recherches Servier, Suresnes, France
J Cardiovasc Pharmacol 42:379-88. 2003....
The thromboxane/endoperoxide receptor (TP): the common villainMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
J Cardiovasc Pharmacol 55:317-32. 2010..Therefore, TP antagonists, because of this triple activity, may have a unique potential for the treatment of cardiovascular disorders...
Neuropeptide Y2 receptors as drug targets for the central regulation of body weightMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Curr Opin Investig Drugs 6:1002-11. 2005..The possibility that long-term NPY Y2 agonism could cause bone thinning and retinal angiogenesis are of particular concern and will need to be investigated as drug discovery moves forward...
Endothelium-derived hyperpolarizing factor: where are we now?Michel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Arterioscler Thromb Vasc Biol 26:1215-25. 2006..Additionally, the endothelium can produce other factors such as lipoxygenases derivatives or hydrogen peroxide (H2O2). These different mechanisms are not necessarily exclusive and can occur simultaneously...
Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient miceFrederic Michel
Institut de Recherches Servier, 11 rue des Moulineaux, 92150 Suresnes, France
Am J Physiol Renal Physiol 294:F120-9. 2008..Increased responsiveness of TP receptors occurs in diabetic ApoE-KO mouse kidneys. Thus early changes in TP receptor-mediated vasoconstrictor activity may participate in the development of kidney disease in atherosclerosis and diabetes...
Nitric oxide: Orchestrator of endothelium-dependent responsesMichel Feletou
Institut Recherches Servier, Suresnes, France
Ann Med 44:694-716. 2012....
TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosisMichel Feletou
Department of Angiology, Institut de Recherches Servier, Suresnes, France
Adv Pharmacol 60:85-106. 2010..TP receptor antagonists represent a promising avenue for the prevention of vascular disease in part because of these pleiotropic actions that extend beyond their antithrombotic properties...
